Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.

about

Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.

Item

http://www.wikidata.org/entity/Q48227776

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Nuclear division cycle 80 prom ...... outcome in colorectal cancer.

@en

Nuclear division cycle 80 prom ...... outcome in colorectal cancer.

@nl

type

Item

label

Nuclear division cycle 80 prom ...... outcome in colorectal cancer.

@en

Nuclear division cycle 80 prom ...... outcome in colorectal cancer.

@nl

prefLabel

Nuclear division cycle 80 prom ...... outcome in colorectal cancer.

@en

Nuclear division cycle 80 prom ...... outcome in colorectal cancer.

@nl

P1476

Nuclear division cycle 80 prom ...... outcome in colorectal cancer.

@en

P2093

Huanlong Qin

http://www.w3.org/2001/XMLSchema#string

Liguo Liu

http://www.w3.org/2001/XMLSchema#string

Linsheng Huang

http://www.w3.org/2001/XMLSchema#string

Zhenshun Song

http://www.w3.org/2001/XMLSchema#string

P2860

The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs)

MAPping the Ndc80 loop in cancer: A possible link between Ndc80/Hec1 overproduction and cancer formation

Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword

The MAPK pathway across different malignancies: a new perspective.

Colorectal cancer statistics, 2017.

Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation.

The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in vitro.

Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.

Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level.

High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients

P304

420-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1284

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xuebing Yan

P577

2018-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29341479

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5806104

http://www.w3.org/2001/XMLSchema#string